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Osaka, Japan.Introduction
Ventricular ﬁbrillation (VF) triggered by premature ventric-
ular contraction (PVC) most frequently originates from the
His-Purkinje system and right ventricular outﬂow tract
(RVOT) in patients with idiopathic VF. Radiofrequency
catheter ablation (RFCA) of triggering PVCs is reportedly
useful for the successful elimination of VF.1–3
The diagnosis of early repolarization (ER) syndrome is
made on the basis of the presence of J-point elevation Z1
mm in Z2 contiguous inferior and/or lateral leads of a
standard 12-lead electrocardiogram (ECG) in patients resus-
citated from otherwise unexperienced VF or polymorphic
ventricular tachycardia (VT).4
However, the efﬁcacy of RFCA of triggering PVCs in ER
syndrome has not been fully evaluated. We report a case in
which successful RFCA of triggering PVCs eliminated a VF
episode in a patient with ER syndrome.Case report
A 37-year-old man was admitted to our hospital after being
resuscitated using an automated external deﬁbrillator for
cardiac arrest due to VF. He experienced sudden syncope
and collapsed at 7:00 PM while performing desk work.
Cardiopulmonary resuscitation was performed immediately
by his colleague. The emergency medical service team
arrived at the place of his cardiac arrest and applied an
automated external deﬁbrillator. The documented presenting
rhythm was VF, which was successfully terminated by the
deﬁbrillator shock. The patient experienced syncope at theKEYWORDS Early repolarization syndrome; Ventricular ﬁbrillation; Catheter
ablation; Premature ventricular contraction; Right ventricular outﬂow tract
(Heart Rhythm Case Reports 2016;2:342–346)
Address reprints and correspondence: Masahiko Takagi, MD, PhD,
FHRS, Department of Cardiovascular Medicine, Osaka City University
Graduate School of Medicine, 1-4-3Asahi-machi, Abeno-ku, Osaka 545-
8585, Japan. E-mail address: m7424580@msic.med.osaka-cu.ac.jp.
2214-0271 B 2016 Heart Rhythm Society. Published by Elsevier Inc. This is an o
(http://creativecommons.org/licenses/by-nc-nd/4.0/).age of 35 without further examination and was not taking any
medicine. There was no familial history of syncope or
sudden cardiac death. On admission, a 12-lead ECG showed
J-point elevationZ1 mm with notching and slurring in leads
I and V4 to V6 (Figure 1A). The maximum J-point amplitude
was 0.8 mV in lead V4. Apart from these ECG abnormalities,
further examination with coronary angiogram and cardiac
magnetic resonance did not reveal any abnormality. An
acetylcholine provocation test showed no coronary artery
spasms. A pilsicainide (a pure sodium channel blocker agent)
provocation test did not reveal Brugada-type ECG pattern.
During hospitalization, a 12-lead ECG revealed monomor-
phic PVC with left bundle branch block morphology and
inferior axis (Figure 1B), and ECG monitoring of lead II
showed monomorphic PVC and ventricular bigeminy
(Figure 1C). Daily ﬂuctuations of J-wave amplitude and
morphology were observed (Figure 2A–D). Finally, the
patient was diagnosed with ER syndrome and was scheduled
for an implantable cardioverter-deﬁbrillator (ICD). How-
ever, in the middle of night of his 22nd day of hospital-
ization, he experienced VF triggered by the same
monomorphic PVC (Figure 1C). The VF was successfully
converted to sinus rhythm with an external direct current
shock at 200 J. ECG monitoring revealed that the QRS
morphology of the ﬁrst beat in this VF episode was identical
to that of the previously recorded PVC. Continuous lidocaine
infusion was started but could not suppress nonsustained
polymorphic VT triggered by the same PVC. After ICD
implantation, we performed RFCA of the monomorphic
PVC responsible for the triggering of VF. The clinical PVC
(PVC1) with left bundle branch block and inferior axis QRS
morphology appeared frequently. A decapolar mapping
catheter was positioned at the His bundle region. An ablation
catheter (NaviStar ThermoCool SmartTouch; Biosense
Webster, Inc, Diamond Bar, CA) was advanced into the
right ventricle through the femoral vein using an 8.5 F
Agilis sheath (St Jude Medical, Inc). Three-dimensionalpen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2016.04.001
KEY TEACHING POINTS
 The high amplitude of the J-point elevation,
horizontal ST segment after early repolarization
(ER), and lower T/R ratio may be associated with a
high risk of arrhythmic death.
 Catheter ablation for ventricular ﬁbrillation (VF)-
triggering monomorphic premature ventricular
contractions (PVCs), originating far from the J
wave location, may be effective in patients with ER
syndrome.
 Radiofrequency catheter ablation (RFCA) for PVCs
from the right ventricular outﬂow tract (RVOT) has
a high success rate; thus, RFCA may be considered
for VF-triggering PVCs from the RVOT even in
patients with ER syndrome.
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St. Paul, MN) activation mapping of PVC1 was performed in
the right ventricle. At a posterolateral site of the RVOT, the
earliest activation was recorded at 20 ms before QRS onset
and a perfect pace map was shown (Figure 3A). Radio-
frequency application at this region was delivered at max-
imum 35 W of power, and PVC1 disappeared after 5.8
seconds of ablation. However, another type of PVC (PVC2)
appeared, with slightly different QRS morphology from that
of PVC1. At a posterior attachment of the RVOT, the earliest
activation was recorded at 27 ms before QRS onset and a
good pace map was shown (Figure 3B). Radiofrequency
application at this region was delivered at maximum 35 W of
power, and PVC2 disappeared after 6.2 seconds of ablation.
However, after successful RFCA, the J-wave pattern did not
disappear. During a follow-up of 18 months, the 24-hour
Holter ECG recording revealed 1 PVC beat per day; there
was no recurrence of VF without taking medication.Discussion
The major ﬁnding in the present case was that RFCA for VF-
triggering PVCs originating from the RVOT area success-
fully suppressed the recurrence of VF in a patient with ER
syndrome but did not eliminate the J wave. To the best of our
knowledge, this is the ﬁrst report of VF-triggering PVCs
originating from the RVOT that were treated successfully
with RFCA in a patient with ER syndrome, with J-wave
elevation in the lateral leads.
The ER syndrome, visible as a J-point elevation on 12-
lead ECG, was formerly thought to be a benign entity.
However, Haïssaguerre et al5 reported a 41% increased risk
of arrhythmia recurrence in patients with idiopathic VF
associated with ER. According to the Heart Rhythm Society/
European Heart Rhythm Association/Asia Paciﬁc Heart
Rhythm Society (HRS/EHRA/APHRS) consensus state-
ment, ER syndrome is diagnosed on the basis of the presence
of J-point elevation Z1 mm in Z2 contiguous inferiorand/or lateral leads of a standard 12-lead ECG in patients
resuscitated from otherwise unexperienced VF or polymorphic
VT.4 In the present case, ECG, cardiac magnetic resonance
imaging, and coronary angiography with acetylcholine prov-
ocation revealed no structural heart diseases. The pilsicainide
provocation test did not induce a type 1 Brugada ECG pattern.
The 12-lead ECG on admission showed J-point elevationZ1
mm in leads I and V4 to V6, and the J-wave amplitude and
morphology showed marked daily ﬂuctuation. Therefore, we
diagnosed this patient with ER syndrome. Moreover, this
patient had high J-wave amplitude in the lateral leads (maximal
J-wave amplitude in lead V4 was 0.8 mV: 5 mm¼ 1 mV) and
horizontal ST segments in leads I and V6 after the J point.
Tikkanen et al6 reported ER patterns associated with high
amplitude (42 mm) accompanied by an increased risk of
arrhythmic death. Additionally, Rosso et al7 reported that the
combination of J wave with descending or horizontal ST
segments increased cardiac events for patients with idiopathic
VF. Furthermore, Roten et al8 reported that patients with
malignant ER have a higher prevalence of low-amplitude T
waves, lower T/R ratio (lead II or V5), and longer QTc interval.
In this case, the T wave was low amplitude (0.4 mV), the T/R
ratio was low (0.2), and the QTc interval was longer (499 ms)
in lead V5. Therefore, ER pattern and the type of ST segment in
this case may be associated with high risk of arrhythmic death.
In the present case, we found that VF-triggering PVCs
originated from the posterior and posterolateral portion of
the RVOT, and we successfully applied RFCA to the
VF-triggering PVCs to eliminate VF. Haïssaguerre et al1
reported VF-triggering PVCs originating predominantly from
the Purkinje system and the RVOT in patients with idiopathic
VF, as well as the feasibility of eliminating or decreasing the
incidence of VF by RFCA for the PVCs. Nogami2 and Noda
et al3 also reported the efﬁcacy of RFCA of VF-triggering
PVCs arising from the RVOT in patients with idiopathic VF.
However, these reports did not investigate the presence of J
waves. Yamashina et al9 reported a high prevalence of J waves
among idiopathic RVOT-VT/PVC patients, and the presence
of J wave was associated with enhanced arrhythmogenicity.
However, they demonstrated that the signiﬁcance of J wave
was limited in terms of prognosis and VF.
The pathophysiological basis of ER is not fully under-
stood. Koncz et al10 showed that an accentuation of trans-
mural gradients in the left ventricular (LV) wall underlay the
repolarization abnormalities responsible for ER syndrome,
giving rise to J-point elevation, and that higher intrinsic
levels of Ito in the inferior left ventricle provided the greater
vulnerability to VF. Moreover, Ghosh et al11 also identiﬁed
short activation–recovery intervals and a marked dispersion
of repolarization in the inferior and lateral regions of the left
ventricle. On the other hand, another hypothesis for the
mechanism leading to ER suggested association between
localized depolarization and repolarization abnormalities.
Recently, Latcu et al12 reported that RFCA of the infer-
oseptal LV substrate was effective in suppressing electrical
storms and disappeared J waves in inferior leads in a patient
with ER syndrome. In the present case, we did not detect
Figure 1 A: The12-lead electrocardiogram (ECG) on admission. The J wave observed in lead I shows slurring, while those in V4 to V6 show notching (black
arrows). The maximum J-point amplitude is 0.8 mV in lead V4. B: Spontaneous clinical premature ventricular contraction (PVC) with left bundle branch block
morphology and inferior axis during hospitalization.C:An ambulatory monitoring ECG in lead II shows monomorphic PVC and ventricular bigeminy (asterisk).
A PVC with the same morphology induced ventricular ﬁbrillation.
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the posterolateral site of the RVOT, and it remains unknown
whether there was local abnormal ventricular activity in the
lateral left ventricle, because we did not perform endocardial
and epicardial mapping in the left ventricle. However, we
succeeded in suppressing VF recurrence by triggering PVCs
originating from the RVOT area; nevertheless, the ER in the
lateral leads did not disappear. Therefore, in the present case,
we speculated that PVCs originating from RVOT might
trigger VF, and that the vulnerable substrate linked to
repolarization and/or depolarization abnormalities in the
lateral LV region was responsible for the maintenance of
VF. During a follow-up of 18 months, 24-hour Holter ECG
recording and ICD telemetry revealed neither triggering
PVCs nor VF recurrence without antiarrhythmic drugs.
However, careful management of VF recurrence is necessary
owing to presence of ER in the lateral leads.The EHRA/HRS/APHRS expert consensus on ventricular
arrhythmias recommends that RFCA of VTs or triggering
focus of VF should be considered in patients with VT/VF
storms when adequate experience is available.13 The success
of RFCA for treatment of idiopathic VF initiated by PVCs
from the RVOT has been reported. Thus, RFCA may be
considered for treatment of VF-triggering PVCs to minimize
the risk of recurrent VF and frequency of ICD discharge even
in patients with ER syndrome.Conclusion
The application of RFCA for VF-triggering PVCs remote
from the location of J waves successfully suppressed the
recurrence of VF. Thus, RFCA for the VF-triggering PVC
may minimize arrhythmic events in ER syndrome.
Figure 2 Daily J-wave ﬂuctuations (black arrows) during hospitalization: A: on admission; B: on day 9 of hospitalization; C: on day 16 of hospitalization;
D: at 1 month of hospitalization. 12-ECG on admission showed more prominent J waves in lateral leads, but J waves disappeared on day 9, and reappeared on
day 16 and increased amplitude at 1 month of hospitalization.
Figure 3 A: The12-lead electrocardiograms (ECGs) of spontaneous clinical PVC1 (left panel) and paced beat (middle panel) and successful ablation site
under ﬂuoroscopy (right panel; white arrow) at the posterolateral site of the right ventricular outﬂow tract (RVOT). B: The12-lead ECGs of spontaneous clinical
PVC2 (left panel) and paced beat (middle panel) and successful ablation site under ﬂuoroscopy (right panel; white arrow) at the posterior attachment of the
RVOT. RAO ¼ right anterior oblique image; LAO ¼ left anterior oblique image; His ¼ His-bundle catheter.
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